Evaluation of the inhibition of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic content of extracts of ten African Ficus species (Moraceae) used traditionally to treat diabetes
- PMID: 23641947
- PMCID: PMC3665600
- DOI: 10.1186/1472-6882-13-94
Evaluation of the inhibition of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic content of extracts of ten African Ficus species (Moraceae) used traditionally to treat diabetes
Abstract
Background: Some Ficus species have been used in traditional African medicine in the treatment of diabetes. The antidiabetic potential of certain species has been confirmed in vivo but the mechanism of activity remains uncertain. The aim of this study was to determine the activity and to investigate the mechanism of antidiabetic activity of ten selected Ficus species through inhibition of α-amylase and α-glucosidase activity, and the possible relationship between these activities, the total polyphenolic content and the antioxidant activity.
Methods: Dried acetone leaf extracts were reconstituted with appropriate solvents and used to determine total polyphenolic content antioxidant activity, α-amylase and α-glucosidase inhibitory activity.
Results: The crude acetone extract of F. lutea had the highest polyphenolic content (56.85 ± 1.82 mg GAE/g of dry material) and the strongest antioxidant activity with a TEAC value of 4.80 ± 0.90. The antioxidant activity of the acetone extracts of the Ficus species may not be ascribed to total polyphenolic content alone. The crude extract at a concentration of 0.5 mg/ml of F. lutea (64.3 ± 3.6%) had the best α-glucosidase (sucrase) inhibitory activity. The EC50 of F. lutea (290 ± 111 μg/ml) was not significantly different from that of F. sycomorus (217 ± 69 μg/ml). The α-amylase inhibitory activity of F. lutea (95.4 ± 1.2%) at a concentration of 1 mg/ml was the highest among the Ficus species screened. The EC50 for F. lutea (9.42 ± 2.01 μ g/ml), though the highest, was not significantly different (p < 0.05) from that of F. craterostoma and F. natalensis. It was apparent that the crude acetone extract of F. lutea is a partially non-competitive inhibitor of α-amylase and α-glucosidase. Based on correlation coefficients polyphenolics may be responsible for α-glucosidase activity but probably not for α-amylase activity.
Conclusion: Antidiabetic activity potential via inhibition of α-amylase and α-glucosidase was discovered in Ficus lutea which has not been previously reported. The acetone extract of the leaves was high in total polyphenolic content and antioxidant activity, and was a potent inhibitor of α-amylase activity. Research is underway to isolate the active compound(s) responsible for the antidiabetic activity and to confirm the in vitro antidiabetic activity and to investigate in vitro toxicity.
Figures
Similar articles
-
Antidiabetic and antioxidant properties of Ficus deltoidea fruit extracts and fractions.BMC Complement Altern Med. 2013 May 29;13:118. doi: 10.1186/1472-6882-13-118. BMC Complement Altern Med. 2013. PMID: 23718315 Free PMC article.
-
In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase.BMC Complement Altern Med. 2012 Jul 31;12:110. doi: 10.1186/1472-6882-12-110. BMC Complement Altern Med. 2012. PMID: 22849553 Free PMC article.
-
Antidiabetic activity of the ethyl acetate fraction of Ficus lutea (Moraceae) leaf extract: comparison of an in vitro assay with an in vivo obese mouse model.BMC Complement Altern Med. 2016 Mar 31;16:110. doi: 10.1186/s12906-016-1087-z. BMC Complement Altern Med. 2016. PMID: 27029351 Free PMC article.
-
Screening of antidiabetic and antioxidant activities of medicinal plants.J Integr Med. 2015 Sep;13(5):297-305. doi: 10.1016/S2095-4964(15)60193-5. J Integr Med. 2015. PMID: 26343100 Review.
-
A comprehensive review on influence of millet processing on carbohydrate-digesting enzyme inhibitors and implications for diabetes management.Crit Rev Biotechnol. 2025 Jun;45(4):743-765. doi: 10.1080/07388551.2024.2423153. Epub 2024 Nov 28. Crit Rev Biotechnol. 2025. PMID: 39610061 Review.
Cited by
-
Antioxidant Status, Antidiabetic Properties and Effects on Caco-2 Cells of Colored and Non-Colored Enriched Extracts of Sweet Cherry Fruits.Nutrients. 2018 Nov 5;10(11):1688. doi: 10.3390/nu10111688. Nutrients. 2018. PMID: 30400658 Free PMC article.
-
Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study.Food Sci Nutr. 2024 Feb 13;12(5):3483-3491. doi: 10.1002/fsn3.4017. eCollection 2024 May. Food Sci Nutr. 2024. PMID: 38726429 Free PMC article.
-
Antidiabetic Activity, Molecular Docking, and ADMET Properties of Compounds Isolated from Bioactive Ethyl Acetate Fraction of Ficus lutea Leaf Extract.Molecules. 2023 Nov 22;28(23):7717. doi: 10.3390/molecules28237717. Molecules. 2023. PMID: 38067448 Free PMC article.
-
Barbeya oleoides Leaves Extracts: In Vitro Carbohydrate Digestive Enzymes Inhibition and Phytochemical Characterization.Molecules. 2021 Oct 15;26(20):6229. doi: 10.3390/molecules26206229. Molecules. 2021. PMID: 34684810 Free PMC article.
-
Herbal therapy: A review of emerging pharmacological tools in the management of diabetes mellitus in Africa.Pharmacogn Mag. 2015 Oct;11(Suppl 2):S258-74. doi: 10.4103/0973-1296.166046. Pharmacogn Mag. 2015. PMID: 26664014 Free PMC article.
References
-
- Anonymous. Part 1: diagnosis and classification of diabetes mellitus. Geneva: Report of a WHO Consultation; 1999. Definition, diagnosis and classification of diabetes mellitus and its complications.
-
- Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamota K, Matsuoka T-A, Matsuhisa M, Yamasaki Y. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal. 2007;9:355–366. - PubMed
-
- Jung M, Park M, Lee HC, Kang YH, Kang ES, Kim SK. Antidiabetic agents from medicinal plants. Curr Med Chem. 2006;13:1203–1218. - PubMed
-
- Jain S, Saraf S. Review on Type 2 diabetes mellitus—its global prevalence and therapeutic strategies. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2010;4:48–56.
-
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials